June 8-11, 2020 | San Diego, CA

BIO Exhibition 

Double Helix Sponsor


Schedule at a glance

Registration Rates

Join the Mailing List

BioProcess Theater
Print Schedule

2019 BPI Theater Logo  

Please use the 2019 BioProcess International Theater Schedule as a reference. 2020 updates coming soon! 

 Since 2008, the BPI Theater, a live, interactive amphitheater located at the heart of the BioProcess Zone (booth #3211), provides biopharmaceutical professionals with a dedicated destination to meet, network, listen and learn about the latest scientific, technology, business, and financial trends impacting biopharmaceutical research, development, and manufacturing.

 In 2019, this live, three-day, complimentary event consisted of targeted panel discussions and individual presentations focusing on: 

Emerging Therapies: Cell & Gene Therapies, Viral Vectors/Vaccines, Manufacturing Strategies for Therapeutic Modalities, Capacity Challenges & Opportunities

Emerging Techniques & Technologies: Drug Product Supply Challenges, Speed to Market, Capacity vs. Cost, SUS vs, Stainless, Analytics & Formulation, Single-Use Bioprocessing

*Open to all attendees

Tuesday, June 4


BioProcess Insider Daily- One-on-One Live Executive Interviews 
10:00 am - 11:00 am

Kicking off the BPI Theater on both Tuesday and Wednesday mornings are face to face interviews conducted by Dan Stanton, veteran industry journalist and editor of BioProcess Insider

10:00 am - 10:15 am: Konstantin Matenzoglu, CEO, CELONIC Group

10:15 am - 10:30 am: Catarina Flyborg, GM, Cell and Gene Therapy Business, GE Healthcare

10:30 am - 10:45 am: Maurice Phelan, Site Head of Cambridge US, Sartorius Stedim Biotech

10:45 am - 11:00 am: Jennifer Cannon, VP  of Operations Commercial Development, ABBVIE

The Cocoon Platform, a Kaleidoscope Approach to Cell Therapy Manufacturing 

11:00 am - 11:20 am

Speaker: Matthew M. Hewitt Ph.D., Head of Clinical Development, Lonza Walkersville 


Standardized Plasmids for Viral Vector Production

 11:20 am - 11:40 am

Speaker: James Brown, Ph.D., Vice President of Corporate Development, Aldevron


Moving Gene Therapies to Market: The Role of Manufacturing Technologies
11:40 am - 12:00 pm

Speaker: Clive Glover, Director of Strategy, Gene and Cell Therapy, Pall Biotech


Cell/Gene/Immuno-Oncology Therapy Modalities - Why Develop One Modality Type vs. Another? How Does This Impact Manufacturing Strategies?

12:00 pm - 12:45 pm

Chair: Patricia Seymour, Managing Director, BPTG, BDO USA


  • Al Gianchetti, President and CEO, XyloCor
  • Alan Moore, VP & Commercial Chief for Advanced Therapies, WuXi Advanced Therapies
  • Susan Jones, SVP Development, Harpoon
  • Diane Blumenthal, Head of Technical Operations, Spark Therapeutics, Inc.


Gene Therapy Product Analysis: Where Historical and Modern Techniques Meet

12:45 pm - 1:05 pm

Speaker: Dr. Andy Topping, CSO, FUJIFILM Diosynth Technologies


Single-Use Stir Tank Bioreactors: A Commercially Viable Strategy for Cell Therapy Manufacturing

1:05 pm - 1:25 pm

Speaker: Alex Klarer, Biomedical Engineer, Hitachi Chemical Advanced Therapeutics Solutions 

*Sponsored by: Distek


 Emerging Therapy Development: Raising the Probability of Success

1:25 pm - 1:45 pm

Speaker: Maurice Phelan, Site Head of Cambridge US, Cell Line & Testing Solutions, Sartorius Stedim Biotech



Cell and Gene Therapies: Keep it in-house or use a third-party?

1:45 pm - 2:30 pm 

Chair: Dan Stanton, BioProcess Insider 


  • Bruce Levine, President Elect, ISCT
  • Joseph Rininger, Ph.D., Director, Cell Gene Therapy, Latham Biopharm Group
  • Felix Hsu, SVP and Global Head, WuXi Advanced Therapies
  • Soenke Brunswieck, Head of  Cell Gene Therapy, CELONIC Group
  • Joe Vitale, Ph.D., Director, Account Management, Hitachi Chemical


Process Development of a Closed CAR T Manufacturing Process

2:30 pm- 2:50 pm

Speaker: Rohin Ilyer, Ph.D., Development Manager, Cell Therapy, GE Healthcare



Harnessing AI & Machine Learning to Improve R&D Efficiency and Reproducibility

2:50 pm - 3:30 pm

Chair: Mike Ward, Chief Content Officer, Informa Pharma Intelligence



  • Magdalena Paluch, Co-Founder & CEO, LabTwin GmbH
  • Ron Alfa, SVP, Translational Discovery Recurison Pharmaceuticals
  • John Piccone, ZS Associates
  • Krishnan Nandabalan, President & CEO, InveniAI Corporation
  • Seth Lederman, CEO & Chariman, TONIX Pharmaceuticals


Start-Up Sourcebook: How to Jump 5 Unforeseen Hurdles to Biotech Success

3:30 pm - 4:15 pm

Chair: Lisa LaMotta, Associate Director of Marketing and Communications, SmartLabs


  • Panelist: Ramani Varanasi, CEO, X-Biotix Therapeutics
  • Panelist: Chris Haskell, Head of West Coast Innovation Center, Bayer Healthcare
  • Panelist: Dan Geffken, Co-Founder, Danforth Advisors
  • Panelist: Luba Greenwood, Business Development & Corporate Ventures, Google’s Verily
  • Panelist: Ailis Tweed-Kent, CEO, Cocoon Biotech
  • Panelist: Teresa Lavoie, Principal, Fish & Richardson 




Wednesday June 5


BioProcess Insider Daily
10:00 am - 11:00 am

Kicking off the BPI Theater on both Tuesday and Wednesday mornings are face to face interviews conducted by Dan Stanton, veteran industry journalist and editor of BioProcess Insider

10:00 am - 10:15 am: Patrick Lucy, CBO, Pfenex, Inc.

10:15 am - 10:30 am: Stéphane Varray, Commercial Development for Midscale, Lonza Pharma and Biotech

10:30 am - 10:45 am: Tom Cartwright, Partner, Morgan Lewis 

10:45 am - 11:00 am: Tracy L. Kinjerski, VP of Business Operations, Avid Bioservices

A Road Map to Licensure of MAb Manufacturing - Implementing Multicolumn Capture Chromatography 
11:00 am - 11:20 am
Speaker: Lilong Huang, Principal Engineer, Manufacturing Operations, Emergent BioSolutions


Qualification of Single Use Sensors for Batch and Continuous Processes 
11:20 am – 11:40 am
Speaker: Jim Furey, General Manager, PendoTECH


Presentation Title TBA Cell Line Development Strategies for Difficult to Express Proteins
11:40 am – 12:00 pm

Presenter: Steven Hager, Ph.D., Sr. Director, Technical Support, Catalent Biologics


Strategies for Implementing New Technologies in an Outsourcing Environment
12:00 pm - 12:45 pm
Chair: Tom Ransohoff, Managing Director, BioProcess Technology Group, BDO USA


  • Jesse McCool, CTO, Cytovance
  • Jésus Zurdo, SVP, Process Sciences, Rentschler
  • Dr. Andy Topping, CSO, FUJIFILM Diosynth Biotechnologies

Next Generation Manufacturing for Bio-Pharmaceuticals
12:45 pm - 1:05 pm

Speaker: Dr. Thomas Page, Vice President, Engineering and Asset Development, FUJIFILM Diosynth Biotechnologies


Quality Considerations Manufacturing for Bio-Pharmaceuticals
1:05 pm - 1:25 pm
Speaker: Ray Marzouk, Vice President, Quality, Avid Bioservices


Blockbuster 2.0 - who's ready?
1:25 pm – 1:45 pm
Speaker: Charles Christy, Director, Commercial Development, Ibex Solutions, Lonza Pharma and Biotech



Capacity Challenge: How Single-Use is Feeding the Demand for Commercial Biologics Manufacturing
1:45 pm – 2:30 pm
Chair: Dan Stanton, BioProcess Insider


  • John Godshalk, Senior Consultant, Biologics Consulting
  • Steven Hager, Ph.D., Sr. Director, Technical Support, Catalent Biologics
  • Gene Yoshioka, Sr. Director, Manufacturing, AVID Bioservices 


Your Success to IND & BLA, Faster and Better 
2:30 pm – 2:50 pm

Speaker: Eun Young Yang, Executive Director, Head of CDO Business Team, Samsung Biologics


China BioPharma - Increasing In-Bound and Out-Bound Investments
2:50 pm - 3:10 pm
Speaker: Eric Langer, President, BioPlan Associates


Presentation Title TBA

3:10 pm – 3:30 pm

Speaker: Letian Kuai Ph.D.  Senior Director, Head of Biology and Informatics, WuXi AppTec


 Breaking Through the Noise - An Approach to Differentiating Your Business

3:30 pm – 3:50 pm 

Speaker: Kiran Chin, CEO, MKA Insights


Presentation TBA

3:50 pm - 4:10 pm


Thursday June 6

Women In Bio (WIB)

11:00 am - 11:45 am
Women In Bio (WIB) presents a panel of Boardroom Ready program graduates for a discussion on career ambitions and the path to a corporate board of directors seat. Among the questions our panelists will discuss are: When did you consider being on a board? Who inspired you and helped you become an accomplished leader? What advice would you give women in the early to middle stages of their careers who want to sit on a board? What do you know now that you wish you had known earlier in your career?

*As of May 28, 2019
Thank you to our 2019 Sponsors

Double Helix Sponsors

Helix Sponsors

Premier Sponsors